Cargando…

Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()

Detalles Bibliográficos
Autores principales: Rodriguez Escobedo, Raul, Alonso Felgueroso, Carlos, Martinez Tames, Gema, Sanchez Ragnarsson, Cecilia, Menendez Torre, Edelmiro Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of SEEN and SED. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913260/
https://www.ncbi.nlm.nih.gov/pubmed/35353690
http://dx.doi.org/10.1016/j.endien.2022.03.002
_version_ 1784667394491285504
author Rodriguez Escobedo, Raul
Alonso Felgueroso, Carlos
Martinez Tames, Gema
Sanchez Ragnarsson, Cecilia
Menendez Torre, Edelmiro Luis
author_facet Rodriguez Escobedo, Raul
Alonso Felgueroso, Carlos
Martinez Tames, Gema
Sanchez Ragnarsson, Cecilia
Menendez Torre, Edelmiro Luis
author_sort Rodriguez Escobedo, Raul
collection PubMed
description
format Online
Article
Text
id pubmed-8913260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier España, S.L.U. on behalf of SEEN and SED.
record_format MEDLINE/PubMed
spelling pubmed-89132602022-03-11 Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes() Rodriguez Escobedo, Raul Alonso Felgueroso, Carlos Martinez Tames, Gema Sanchez Ragnarsson, Cecilia Menendez Torre, Edelmiro Luis Endocrinol Diabetes Nutr (Engl Ed) Scientific Letter Published by Elsevier España, S.L.U. on behalf of SEEN and SED. 2022-04 2022-03-11 /pmc/articles/PMC8913260/ /pubmed/35353690 http://dx.doi.org/10.1016/j.endien.2022.03.002 Text en © 2022 Published by Elsevier España, S.L.U. on behalf of SEEN and SED. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Scientific Letter
Rodriguez Escobedo, Raul
Alonso Felgueroso, Carlos
Martinez Tames, Gema
Sanchez Ragnarsson, Cecilia
Menendez Torre, Edelmiro Luis
Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()
title Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()
title_full Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()
title_fullStr Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()
title_full_unstemmed Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()
title_short Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes()
title_sort evaluation of the consequences of the covid-19 lockdown on glycemic control in type 1 diabetes()
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913260/
https://www.ncbi.nlm.nih.gov/pubmed/35353690
http://dx.doi.org/10.1016/j.endien.2022.03.002
work_keys_str_mv AT rodriguezescobedoraul evaluationoftheconsequencesofthecovid19lockdownonglycemiccontrolintype1diabetes
AT alonsofelguerosocarlos evaluationoftheconsequencesofthecovid19lockdownonglycemiccontrolintype1diabetes
AT martineztamesgema evaluationoftheconsequencesofthecovid19lockdownonglycemiccontrolintype1diabetes
AT sanchezragnarssoncecilia evaluationoftheconsequencesofthecovid19lockdownonglycemiccontrolintype1diabetes
AT menendeztorreedelmiroluis evaluationoftheconsequencesofthecovid19lockdownonglycemiccontrolintype1diabetes